# Supplementation of YMETA, on Gut Health, Immunity and Metabolism in Pre-diabetic Adult Population

> **NCT05400525** · NA · COMPLETED · sponsor: **University of Roehampton** · enrollment: 30 (actual)

## Conditions studied

- Pre-diabetes

## Interventions

- **DIETARY_SUPPLEMENT:** YMETA
- **OTHER:** Placebo control

## Key facts

- **NCT ID:** NCT05400525
- **Lead sponsor:** University of Roehampton
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-15
- **Primary completion:** 2023-06-10
- **Final completion:** 2023-09-20
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-11-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05400525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05400525, "Supplementation of YMETA, on Gut Health, Immunity and Metabolism in Pre-diabetic Adult Population". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05400525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*